1 Introduction to Research & Analysis Reports
1.1 Bispecific Antibodies Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bispecific Antibodies Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bispecific Antibodies Drug Overall Market Size
2.1 Global Bispecific Antibodies Drug Market Size: 2022 VS 2029
2.2 Global Bispecific Antibodies Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bispecific Antibodies Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Bispecific Antibodies Drug Players in Global Market
3.2 Top Global Bispecific Antibodies Drug Companies Ranked by Revenue
3.3 Global Bispecific Antibodies Drug Revenue by Companies
3.4 Global Bispecific Antibodies Drug Sales by Companies
3.5 Global Bispecific Antibodies Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bispecific Antibodies Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bispecific Antibodies Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bispecific Antibodies Drug Players in Global Market
3.8.1 List of Global Tier 1 Bispecific Antibodies Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Bispecific Antibodies Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Bispecific Antibodies Drug Market Size Markets, 2022 & 2029
4.1.2 Blincyto
4.1.3 Kimmtrak
4.1.4 Hemlibra
4.2 By Type – Global Bispecific Antibodies Drug Revenue & Forecasts
4.2.1 By Type – Global Bispecific Antibodies Drug Revenue, 2018-2023
4.2.2 By Type – Global Bispecific Antibodies Drug Revenue, 2024-2029
4.2.3 By Type – Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Bispecific Antibodies Drug Sales & Forecasts
4.3.1 By Type – Global Bispecific Antibodies Drug Sales, 2018-2023
4.3.2 By Type – Global Bispecific Antibodies Drug Sales, 2024-2029
4.3.3 By Type – Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
4.4 By Type – Global Bispecific Antibodies Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bispecific Antibodies Drug Market Size, 2022 & 2029
5.1.2 Hematological Cancers
5.1.3 Solid Tumors
5.2 By Application – Global Bispecific Antibodies Drug Revenue & Forecasts
5.2.1 By Application – Global Bispecific Antibodies Drug Revenue, 2018-2023
5.2.2 By Application – Global Bispecific Antibodies Drug Revenue, 2024-2029
5.2.3 By Application – Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Bispecific Antibodies Drug Sales & Forecasts
5.3.1 By Application – Global Bispecific Antibodies Drug Sales, 2018-2023
5.3.2 By Application – Global Bispecific Antibodies Drug Sales, 2024-2029
5.3.3 By Application – Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
5.4 By Application – Global Bispecific Antibodies Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Bispecific Antibodies Drug Market Size, 2022 & 2029
6.2 By Region – Global Bispecific Antibodies Drug Revenue & Forecasts
6.2.1 By Region – Global Bispecific Antibodies Drug Revenue, 2018-2023
6.2.2 By Region – Global Bispecific Antibodies Drug Revenue, 2024-2029
6.2.3 By Region – Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Bispecific Antibodies Drug Sales & Forecasts
6.3.1 By Region – Global Bispecific Antibodies Drug Sales, 2018-2023
6.3.2 By Region – Global Bispecific Antibodies Drug Sales, 2024-2029
6.3.3 By Region – Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Bispecific Antibodies Drug Revenue, 2018-2029
6.4.2 By Country – North America Bispecific Antibodies Drug Sales, 2018-2029
6.4.3 US Bispecific Antibodies Drug Market Size, 2018-2029
6.4.4 Canada Bispecific Antibodies Drug Market Size, 2018-2029
6.4.5 Mexico Bispecific Antibodies Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Bispecific Antibodies Drug Revenue, 2018-2029
6.5.2 By Country – Europe Bispecific Antibodies Drug Sales, 2018-2029
6.5.3 Germany Bispecific Antibodies Drug Market Size, 2018-2029
6.5.4 France Bispecific Antibodies Drug Market Size, 2018-2029
6.5.5 U.K. Bispecific Antibodies Drug Market Size, 2018-2029
6.5.6 Italy Bispecific Antibodies Drug Market Size, 2018-2029
6.5.7 Russia Bispecific Antibodies Drug Market Size, 2018-2029
6.5.8 Nordic Countries Bispecific Antibodies Drug Market Size, 2018-2029
6.5.9 Benelux Bispecific Antibodies Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Bispecific Antibodies Drug Revenue, 2018-2029
6.6.2 By Region – Asia Bispecific Antibodies Drug Sales, 2018-2029
6.6.3 China Bispecific Antibodies Drug Market Size, 2018-2029
6.6.4 Japan Bispecific Antibodies Drug Market Size, 2018-2029
6.6.5 South Korea Bispecific Antibodies Drug Market Size, 2018-2029
6.6.6 Southeast Asia Bispecific Antibodies Drug Market Size, 2018-2029
6.6.7 India Bispecific Antibodies Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Bispecific Antibodies Drug Revenue, 2018-2029
6.7.2 By Country – South America Bispecific Antibodies Drug Sales, 2018-2029
6.7.3 Brazil Bispecific Antibodies Drug Market Size, 2018-2029
6.7.4 Argentina Bispecific Antibodies Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Bispecific Antibodies Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Bispecific Antibodies Drug Sales, 2018-2029
6.8.3 Turkey Bispecific Antibodies Drug Market Size, 2018-2029
6.8.4 Israel Bispecific Antibodies Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Bispecific Antibodies Drug Market Size, 2018-2029
6.8.6 UAE Bispecific Antibodies Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Bispecific Antibodies Drug Major Product Offerings
7.1.4 Amgen Bispecific Antibodies Drug Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Immunocore
7.2.1 Immunocore Company Summary
7.2.2 Immunocore Business Overview
7.2.3 Immunocore Bispecific Antibodies Drug Major Product Offerings
7.2.4 Immunocore Bispecific Antibodies Drug Sales and Revenue in Global (2018-2023)
7.2.5 Immunocore Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Bispecific Antibodies Drug Major Product Offerings
7.3.4 Roche Bispecific Antibodies Drug Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
8 Global Bispecific Antibodies Drug Production Capacity, Analysis
8.1 Global Bispecific Antibodies Drug Production Capacity, 2018-2029
8.2 Bispecific Antibodies Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Bispecific Antibodies Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bispecific Antibodies Drug Supply Chain Analysis
10.1 Bispecific Antibodies Drug Industry Value Chain
10.2 Bispecific Antibodies Drug Upstream Market
10.3 Bispecific Antibodies Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bispecific Antibodies Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の二重特異性抗体医薬品市場予測2023-2029：ブリンサイト、キムトラック、ヘムライブラ |
| 【英語タイトル】Bispecific Antibodies Drug Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5719 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：75 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の二重特異性抗体医薬品市場規模と予測を収録しています。・世界の二重特異性抗体医薬品市場：売上、2018年-2023年、2024年-2029年 ・世界の二重特異性抗体医薬品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の二重特異性抗体医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ブリンサイト」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 二重特異性抗体医薬品のグローバル主要企業は、Amgen、 Immunocore、 Rocheなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、二重特異性抗体医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の二重特異性抗体医薬品市場：タイプ別、2018年-2023年、2024年-2029年 世界の二重特異性抗体医薬品市場：タイプ別市場シェア、2022年 ・ブリンサイト、キムトラック、ヘムライブラ 世界の二重特異性抗体医薬品市場：用途別、2018年-2023年、2024年-2029年 世界の二重特異性抗体医薬品市場：用途別市場シェア、2022年 ・血液がん、固形がん 世界の二重特異性抗体医薬品市場：地域・国別、2018年-2023年、2024年-2029年 世界の二重特異性抗体医薬品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における二重特異性抗体医薬品のグローバル売上、2018年-2023年 ・主要企業における二重特異性抗体医薬品のグローバル売上シェア、2022年 ・主要企業における二重特異性抗体医薬品のグローバル販売量、2018年-2023年 ・主要企業における二重特異性抗体医薬品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Amgen、 Immunocore、 Roche ************************************************************* ・調査・分析レポートの概要 二重特異性抗体医薬品市場の定義 市場セグメント 世界の二重特異性抗体医薬品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の二重特異性抗体医薬品市場規模 世界の二重特異性抗体医薬品市場規模：2022年 VS 2029年 世界の二重特異性抗体医薬品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの二重特異性抗体医薬品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の二重特異性抗体医薬品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ブリンサイト、キムトラック、ヘムライブラ 二重特異性抗体医薬品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：血液がん、固形がん 二重特異性抗体医薬品の用途別グローバル売上・予測 ・地域別市場分析 地域別二重特異性抗体医薬品市場規模 2022年と2029年 地域別二重特異性抗体医薬品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Amgen、 Immunocore、 Roche ... |
A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibodies Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibodies Drug. This report contains market size and forecasts of Bispecific Antibodies Drug in global, including the following market information:
Global Bispecific Antibodies Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bispecific Antibodies Drug Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Bispecific Antibodies Drug companies in 2022 (%)
The global Bispecific Antibodies Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Blincyto Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bispecific Antibodies Drug include Amgen, Immunocore and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bispecific Antibodies Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bispecific Antibodies Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bispecific Antibodies Drug Market Segment Percentages, by Type, 2022 (%)
Blincyto
Kimmtrak
Hemlibra
Global Bispecific Antibodies Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bispecific Antibodies Drug Market Segment Percentages, by Application, 2022 (%)
Hematological Cancers
Solid Tumors
Global Bispecific Antibodies Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bispecific Antibodies Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bispecific Antibodies Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bispecific Antibodies Drug revenues share in global market, 2022 (%)
Key companies Bispecific Antibodies Drug sales in global market, 2018-2023 (Estimated), (Units)
Key companies Bispecific Antibodies Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Immunocore
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bispecific Antibodies Drug, market overview.
Chapter 2: Global Bispecific Antibodies Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Bispecific Antibodies Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bispecific Antibodies Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bispecific Antibodies Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の二重特異性抗体医薬品市場予測2023-2029：ブリンサイト、キムトラック、ヘムライブラ] (コード：MMG23JU5719)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の二重特異性抗体医薬品市場予測2023-2029：ブリンサイト、キムトラック、ヘムライブラ]についてメールでお問い合わせ |
